Tissue-engineered lymphatic graft for the treatment of lymphedema
Identifieur interne : 002391 ( Main/Exploration ); précédent : 002390; suivant : 002392Tissue-engineered lymphatic graft for the treatment of lymphedema
Auteurs : Muholan Kanapathy [Royaume-Uni] ; Nikhil M. Patel [Royaume-Uni] ; Deepak M. Kalaskar [Royaume-Uni] ; Afshin Mosahebi [Royaume-Uni] ; Babak J. Mehrara [États-Unis] ; Alexander M. Seifalian [Royaume-Uni]Source :
- The Journal of surgical research [ 0022-4804 ] ; 2014.
Descripteurs français
- KwdFr :
- MESH :
English descriptors
- KwdEn :
- MESH :
- methods : Nanotechnology, Tissue Engineering.
- physiology : Lymphatic Vessels.
- surgery : Lymphedema.
- therapy : Lymphedema.
- transplantation : Lymphatic Vessels.
- Humans, Regeneration.
Abstract
Lymphedema is a chronic debilitating condition and curative treatment is yet to be found. Tissue engineering approach, which combines cellular components, scaffold, and molecular signals hold great potential in the treatment of secondary lymphedema with the advent of lymphatic graft to reconstruct damaged collecting lymphatic vessel. This review highlights the ideal characteristics of lymphatic graft, the limitation and challenges faced, and the approaches in developing tissue-engineered lymphatic graft.
Literature on tissue engineering of lymphatic system and lymphatic tissue biology was reviewed.
The prime challenge in the design and manufacturing of this graft is producing endothelialized conduit with intraluminal valves. Suitable scaffold material is needed to ensure stability and functionality of the construct. Endothelialization of the construct can be enhanced via biofunctionalization and nanotopography, which mimics extracellular matrix. Nanocomposite polymers with improved performance over existing biomaterials are likely to benefit the development of lymphatic graft.
With the in-depth understanding of tissue engineering, nanotechnology, and improved knowledge on the biology of lymphatic regeneration, the aspiration to develop successful lymphatic graft is well achievable.
Url:
DOI: 10.1016/j.jss.2014.07.059
PubMed: 25248852
PubMed Central: 4394124
Affiliations:
- Royaume-Uni, États-Unis
- Angleterre, Grand Londres, État de New York
- Londres
- University College de Londres
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: 003385
- to stream Pmc, to step Curation: 003384
- to stream Pmc, to step Checkpoint: 001675
- to stream PubMed, to step Corpus: 001300
- to stream PubMed, to step Curation: 001300
- to stream PubMed, to step Checkpoint: 001300
- to stream Ncbi, to step Merge: 006B29
- to stream Ncbi, to step Curation: 006B29
- to stream Ncbi, to step Checkpoint: 006B29
- to stream Main, to step Merge: 002394
- to stream Main, to step Curation: 002391
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Tissue-engineered lymphatic graft for the treatment of lymphedema</title><author><name sortKey="Kanapathy, Muholan" sort="Kanapathy, Muholan" uniqKey="Kanapathy M" first="Muholan" last="Kanapathy">Muholan Kanapathy</name><affiliation wicri:level="4"><nlm:aff id="A1">Division of Surgery & Interventional Science, UCL Centre for Nanotechnology & Regenerative Medicine, University College London, London, United Kingdom</nlm:aff><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Division of Surgery & Interventional Science, UCL Centre for Nanotechnology & Regenerative Medicine, University College London, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region><settlement type="city">Londres</settlement></placeName><orgName type="university">University College de Londres</orgName></affiliation></author><author><name sortKey="Patel, Nikhil M" sort="Patel, Nikhil M" uniqKey="Patel N" first="Nikhil M." last="Patel">Nikhil M. Patel</name><affiliation wicri:level="4"><nlm:aff id="A1">Division of Surgery & Interventional Science, UCL Centre for Nanotechnology & Regenerative Medicine, University College London, London, United Kingdom</nlm:aff><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Division of Surgery & Interventional Science, UCL Centre for Nanotechnology & Regenerative Medicine, University College London, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region><settlement type="city">Londres</settlement></placeName><orgName type="university">University College de Londres</orgName></affiliation></author><author><name sortKey="Kalaskar, Deepak M" sort="Kalaskar, Deepak M" uniqKey="Kalaskar D" first="Deepak M." last="Kalaskar">Deepak M. Kalaskar</name><affiliation wicri:level="4"><nlm:aff id="A1">Division of Surgery & Interventional Science, UCL Centre for Nanotechnology & Regenerative Medicine, University College London, London, United Kingdom</nlm:aff><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Division of Surgery & Interventional Science, UCL Centre for Nanotechnology & Regenerative Medicine, University College London, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region><settlement type="city">Londres</settlement></placeName><orgName type="university">University College de Londres</orgName></affiliation></author><author><name sortKey="Mosahebi, Afshin" sort="Mosahebi, Afshin" uniqKey="Mosahebi A" first="Afshin" last="Mosahebi">Afshin Mosahebi</name><affiliation wicri:level="4"><nlm:aff id="A1">Division of Surgery & Interventional Science, UCL Centre for Nanotechnology & Regenerative Medicine, University College London, London, United Kingdom</nlm:aff><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Division of Surgery & Interventional Science, UCL Centre for Nanotechnology & Regenerative Medicine, University College London, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region><settlement type="city">Londres</settlement></placeName><orgName type="university">University College de Londres</orgName></affiliation><affiliation wicri:level="3"><nlm:aff id="A2">Department of Plastic and Reconstructive Surgery, Royal Free London NHS Foundation Trust Hospital, London, United Kingdom</nlm:aff><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Plastic and Reconstructive Surgery, Royal Free London NHS Foundation Trust Hospital, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Mehrara, Babak J" sort="Mehrara, Babak J" uniqKey="Mehrara B" first="Babak J." last="Mehrara">Babak J. Mehrara</name><affiliation wicri:level="2"><nlm:aff id="A3">Department of Plastic and Reconstructive Surgery, Memorial Sloan-Kettering Cancer Centre, New York</nlm:aff><country xml:lang="fr">États-Unis</country><placeName><region type="state">État de New York</region></placeName><wicri:cityArea>Department of Plastic and Reconstructive Surgery, Memorial Sloan-Kettering Cancer Centre</wicri:cityArea></affiliation></author><author><name sortKey="Seifalian, Alexander M" sort="Seifalian, Alexander M" uniqKey="Seifalian A" first="Alexander M." last="Seifalian">Alexander M. Seifalian</name><affiliation wicri:level="4"><nlm:aff id="A1">Division of Surgery & Interventional Science, UCL Centre for Nanotechnology & Regenerative Medicine, University College London, London, United Kingdom</nlm:aff><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Division of Surgery & Interventional Science, UCL Centre for Nanotechnology & Regenerative Medicine, University College London, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region><settlement type="city">Londres</settlement></placeName><orgName type="university">University College de Londres</orgName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">25248852</idno><idno type="pmc">4394124</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4394124</idno><idno type="RBID">PMC:4394124</idno><idno type="doi">10.1016/j.jss.2014.07.059</idno><date when="2014">2014</date><idno type="wicri:Area/Pmc/Corpus">003385</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">003385</idno><idno type="wicri:Area/Pmc/Curation">003384</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">003384</idno><idno type="wicri:Area/Pmc/Checkpoint">001675</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">001675</idno><idno type="wicri:source">PubMed</idno><idno type="wicri:Area/PubMed/Corpus">001300</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001300</idno><idno type="wicri:Area/PubMed/Curation">001300</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001300</idno><idno type="wicri:Area/PubMed/Checkpoint">001300</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001300</idno><idno type="wicri:Area/Ncbi/Merge">006B29</idno><idno type="wicri:Area/Ncbi/Curation">006B29</idno><idno type="wicri:Area/Ncbi/Checkpoint">006B29</idno><idno type="wicri:doubleKey">0022-4804:2014:Kanapathy M:tissue:engineered:lymphatic</idno><idno type="wicri:Area/Main/Merge">002394</idno><idno type="wicri:Area/Main/Curation">002391</idno><idno type="wicri:Area/Main/Exploration">002391</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Tissue-engineered lymphatic graft for the treatment of lymphedema</title><author><name sortKey="Kanapathy, Muholan" sort="Kanapathy, Muholan" uniqKey="Kanapathy M" first="Muholan" last="Kanapathy">Muholan Kanapathy</name><affiliation wicri:level="4"><nlm:aff id="A1">Division of Surgery & Interventional Science, UCL Centre for Nanotechnology & Regenerative Medicine, University College London, London, United Kingdom</nlm:aff><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Division of Surgery & Interventional Science, UCL Centre for Nanotechnology & Regenerative Medicine, University College London, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region><settlement type="city">Londres</settlement></placeName><orgName type="university">University College de Londres</orgName></affiliation></author><author><name sortKey="Patel, Nikhil M" sort="Patel, Nikhil M" uniqKey="Patel N" first="Nikhil M." last="Patel">Nikhil M. Patel</name><affiliation wicri:level="4"><nlm:aff id="A1">Division of Surgery & Interventional Science, UCL Centre for Nanotechnology & Regenerative Medicine, University College London, London, United Kingdom</nlm:aff><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Division of Surgery & Interventional Science, UCL Centre for Nanotechnology & Regenerative Medicine, University College London, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region><settlement type="city">Londres</settlement></placeName><orgName type="university">University College de Londres</orgName></affiliation></author><author><name sortKey="Kalaskar, Deepak M" sort="Kalaskar, Deepak M" uniqKey="Kalaskar D" first="Deepak M." last="Kalaskar">Deepak M. Kalaskar</name><affiliation wicri:level="4"><nlm:aff id="A1">Division of Surgery & Interventional Science, UCL Centre for Nanotechnology & Regenerative Medicine, University College London, London, United Kingdom</nlm:aff><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Division of Surgery & Interventional Science, UCL Centre for Nanotechnology & Regenerative Medicine, University College London, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region><settlement type="city">Londres</settlement></placeName><orgName type="university">University College de Londres</orgName></affiliation></author><author><name sortKey="Mosahebi, Afshin" sort="Mosahebi, Afshin" uniqKey="Mosahebi A" first="Afshin" last="Mosahebi">Afshin Mosahebi</name><affiliation wicri:level="4"><nlm:aff id="A1">Division of Surgery & Interventional Science, UCL Centre for Nanotechnology & Regenerative Medicine, University College London, London, United Kingdom</nlm:aff><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Division of Surgery & Interventional Science, UCL Centre for Nanotechnology & Regenerative Medicine, University College London, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region><settlement type="city">Londres</settlement></placeName><orgName type="university">University College de Londres</orgName></affiliation><affiliation wicri:level="3"><nlm:aff id="A2">Department of Plastic and Reconstructive Surgery, Royal Free London NHS Foundation Trust Hospital, London, United Kingdom</nlm:aff><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Plastic and Reconstructive Surgery, Royal Free London NHS Foundation Trust Hospital, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Mehrara, Babak J" sort="Mehrara, Babak J" uniqKey="Mehrara B" first="Babak J." last="Mehrara">Babak J. Mehrara</name><affiliation wicri:level="2"><nlm:aff id="A3">Department of Plastic and Reconstructive Surgery, Memorial Sloan-Kettering Cancer Centre, New York</nlm:aff><country xml:lang="fr">États-Unis</country><placeName><region type="state">État de New York</region></placeName><wicri:cityArea>Department of Plastic and Reconstructive Surgery, Memorial Sloan-Kettering Cancer Centre</wicri:cityArea></affiliation></author><author><name sortKey="Seifalian, Alexander M" sort="Seifalian, Alexander M" uniqKey="Seifalian A" first="Alexander M." last="Seifalian">Alexander M. Seifalian</name><affiliation wicri:level="4"><nlm:aff id="A1">Division of Surgery & Interventional Science, UCL Centre for Nanotechnology & Regenerative Medicine, University College London, London, United Kingdom</nlm:aff><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Division of Surgery & Interventional Science, UCL Centre for Nanotechnology & Regenerative Medicine, University College London, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region><settlement type="city">Londres</settlement></placeName><orgName type="university">University College de Londres</orgName></affiliation></author></analytic><series><title level="j">The Journal of surgical research</title><idno type="ISSN">0022-4804</idno><idno type="eISSN">1095-8673</idno><imprint><date when="2014">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Humans</term><term>Lymphatic Vessels (physiology)</term><term>Lymphatic Vessels (transplantation)</term><term>Lymphedema (surgery)</term><term>Lymphedema (therapy)</term><term>Nanotechnology (methods)</term><term>Regeneration</term><term>Tissue Engineering (methods)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Humains</term><term>Ingénierie tissulaire ()</term><term>Lymphoedème ()</term><term>Nanotechnologie ()</term><term>Régénération</term><term>Vaisseaux lymphatiques (physiologie)</term><term>Vaisseaux lymphatiques (transplantation)</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Nanotechnology</term><term>Tissue Engineering</term></keywords><keywords scheme="MESH" qualifier="physiologie" xml:lang="fr"><term>Vaisseaux lymphatiques</term></keywords><keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Lymphatic Vessels</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="transplantation" xml:lang="en"><term>Lymphatic Vessels</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Humans</term><term>Regeneration</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Humains</term><term>Ingénierie tissulaire</term><term>Lymphoedème</term><term>Nanotechnologie</term><term>Régénération</term><term>Vaisseaux lymphatiques</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><sec id="S1"><title>Background</title><p id="P1">Lymphedema is a chronic debilitating condition and curative treatment is yet to be found. Tissue engineering approach, which combines cellular components, scaffold, and molecular signals hold great potential in the treatment of secondary lymphedema with the advent of lymphatic graft to reconstruct damaged collecting lymphatic vessel. This review highlights the ideal characteristics of lymphatic graft, the limitation and challenges faced, and the approaches in developing tissue-engineered lymphatic graft.</p></sec><sec id="S2"><title>Methods</title><p id="P2">Literature on tissue engineering of lymphatic system and lymphatic tissue biology was reviewed.</p></sec><sec id="S3"><title>Results</title><p id="P3">The prime challenge in the design and manufacturing of this graft is producing endothelialized conduit with intraluminal valves. Suitable scaffold material is needed to ensure stability and functionality of the construct. Endothelialization of the construct can be enhanced via biofunctionalization and nanotopography, which mimics extracellular matrix. Nanocomposite polymers with improved performance over existing biomaterials are likely to benefit the development of lymphatic graft.</p></sec><sec id="S4"><title>Conclusions</title><p id="P4">With the in-depth understanding of tissue engineering, nanotechnology, and improved knowledge on the biology of lymphatic regeneration, the aspiration to develop successful lymphatic graft is well achievable.</p></sec></div></front></TEI><affiliations><list><country><li>Royaume-Uni</li><li>États-Unis</li></country><region><li>Angleterre</li><li>Grand Londres</li><li>État de New York</li></region><settlement><li>Londres</li></settlement><orgName><li>University College de Londres</li></orgName></list><tree><country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Kanapathy, Muholan" sort="Kanapathy, Muholan" uniqKey="Kanapathy M" first="Muholan" last="Kanapathy">Muholan Kanapathy</name></region><name sortKey="Kalaskar, Deepak M" sort="Kalaskar, Deepak M" uniqKey="Kalaskar D" first="Deepak M." last="Kalaskar">Deepak M. Kalaskar</name><name sortKey="Mosahebi, Afshin" sort="Mosahebi, Afshin" uniqKey="Mosahebi A" first="Afshin" last="Mosahebi">Afshin Mosahebi</name><name sortKey="Mosahebi, Afshin" sort="Mosahebi, Afshin" uniqKey="Mosahebi A" first="Afshin" last="Mosahebi">Afshin Mosahebi</name><name sortKey="Patel, Nikhil M" sort="Patel, Nikhil M" uniqKey="Patel N" first="Nikhil M." last="Patel">Nikhil M. Patel</name><name sortKey="Seifalian, Alexander M" sort="Seifalian, Alexander M" uniqKey="Seifalian A" first="Alexander M." last="Seifalian">Alexander M. Seifalian</name></country><country name="États-Unis"><region name="État de New York"><name sortKey="Mehrara, Babak J" sort="Mehrara, Babak J" uniqKey="Mehrara B" first="Babak J." last="Mehrara">Babak J. Mehrara</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002391 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002391 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= PMC:4394124
|texte= Tissue-engineered lymphatic graft for the treatment of lymphedema
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:25248852" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |